PRESS RELEASE published on 08/13/2026 at 15:50, 28 days 20 hours ago Form 8.3 - The Vanguard Group, Inc.: DCC plc The Vanguard Group, Inc. discloses a 5.84% stake in DCC plc as of 12 August 2026. Details of securities holdings and purchases are revealed in accordance with Irish takeover rules The Vanguard Group Stake Disclosure Securities Holdings Irish Takeover Rules DCC Plc
PRESS RELEASE published on 08/13/2026 at 15:50, 28 days 20 hours ago Bloom Security Finds ‘Extension Resurrection’ Flaw That Could Enable Zero-Click RCE Across 500,000+ Downloads New York, USA, August 13th, 2026, FinanceWire
PRESS RELEASE published on 08/13/2026 at 15:49, 28 days 20 hours ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5% stake in Beazley plc through Form 8.3 filing. Purchase of 41,081 securities at 12.93 GBP per unit Form 8.3 Vanguard Group Stake Disclosure Securities Purchase Beazley Plc
PRESS RELEASE published on 08/13/2026 at 15:48, 28 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses 5.45% stake in Rotork plc. Purchased 9,180 securities at 4.87 GBP per unit on 12 August 2026 The Vanguard Group, Inc. Stake Disclosure Securities Purchase Rotork Plc GBP 4.87
PRESS RELEASE published on 08/13/2026 at 15:48, 28 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses a 2.72% ownership in Schroders plc. Stock purchased at 5.83 GBP per unit The Vanguard Group Stock Purchase Schroders Plc Ownership Disclosure Financial Disclosure
PRESS RELEASE published on 08/13/2026 at 15:47, 28 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses a 4.77% interest in Tate & Lyle plc. Details of securities holdings and dealings provided as per Rule 8.3 of Takeover Code Securities The Vanguard Group, Inc. Disclosure Takeover Code Tate & Lyle Plc
PRESS RELEASE published on 08/13/2026 at 15:47, 28 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. files Form 8.3 with the disclosure of interests in Spire Healthcare Group plc securities as of 12 August 2026 Securities Form 8.3 Disclosure Vanguard Group Spire Healthcare Group Plc
PRESS RELEASE published on 08/13/2026 at 15:46, 28 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: easyJet plc The Vanguard Group, Inc. discloses 3.15% stake in easyJet plc as per Form 8.3 under the Takeover Code. Details in public disclosure Form 8.3 Takeover Code Vanguard Group Stake Disclosure EasyJet Plc
PRESS RELEASE published on 08/13/2026 at 15:45, 28 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: SEGRO plc The Vanguard Group, Inc. discloses a 5.66% stake in SEGRO plc as of 12 August 2026. Disclosures also involve Prologis, Inc. related to a cash offer The Vanguard Group Stake Disclosure Cash Offer SEGRO PLC Prologis Inc.
PRESS RELEASE published on 08/13/2026 at 15:45, 28 days 21 hours ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses 5.31% stake in LondonMetric Property plc and 0.92% in Schroder Real Estate Investment Trust Limited. Additional disclosure on Picton Property Income Limited LondonMetric Property Plc The Vanguard Group Stake Disclosure Picton Property Income Limited Schroder Real Estate Investment Trust Limited
Published on 09/11/2026 at 04:00, 8 hours 49 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 14 hours 24 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 21 hours 29 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 21 hours 49 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 11:43, 1 hour 6 minutes ago Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 1 hour 13 minutes ago EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 1 hour 19 minutes ago Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 34 minutes ago TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050
Published on 09/11/2026 at 07:00, 5 hours 49 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 5 hours 49 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 5 hours 49 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 17 hours 19 minutes ago Availability of the 2026 Interim Financial Report
![Logo of [UNKNOWN]](https://logos.symex.be/img/.jpg)
